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ABSTRACT
A POSSIBLE POSITIVE FEEDBACK MODULATION OF ACETYLCHOLINE 
RELEASE THROUGH THE STIMULATION OF ALPHA-7 NICOTINIC 
ACETYLCHOLINE RECEPTORS ON BIPOLAR NEURONS IN PIG RETINA
by Viralkumar Patel
Glaucoma is associated with excitotoxicity in which increased glutamate release 
leads to apoptotic death o f retinal ganglion cells (RGCs). Acetylcholine (ACh) has shown 
neuroprotection o f RGCs through the stimulation o f RGCs’ nicotinic acetylcholine 
receptors (nAChRs). The cholinergic amacrine cells are the only cells in retina which 
synthesize and release ACh. They get excitatory inputs from bipolar cells. The presence 
o f aTnicotinic acetylcholine receptors (aTnAChRs) on the cholinergic amacrines, bipolar 
cells and RGCs is documented. Recently, stimulation o f presynaptic nAChRs o f 
cholinergic cells was shown to enhance ACh release in the rat superior cervical ganglion. 
Therefore, we hypothesized that aTnAChRs stimulation by tropisetron and PNU282987 
(a7nAChR agonists) could induce ACh release through either direct stimulation o f 
cholinergic amacrine u7nAChRs or indirect stimulation o f bipolar u7nAChRs. For ACh 
release studies, pig eyes were dissected and cholinergic amacrine cells were labeled with 
40pCi o f ^H-choline in which the retina was flashed with light (3Hz) for 30 minutes to 
maximize ^H-choline uptake. Then, the eyecup was transferred to a perfusion chamber, 
washed for 20 minutes. 1 minute output fractions were collected into vials and prepared 
for liquid scintillation counting. To assess the viability o f the preparation, light and 
kainate were applied. Light (2-3 fold increase), kainate (3-4 fold; lO-lOOpM), a7nAChR 
agonists (2-4 fold; O.Ol-lOOnM) evoked ACh release greater than the baseline in the 
absence o f DNQX (a glutamate receptor antagonist). In the presence o f DNQX, which 
blocked bipolar input to cholinergic cells, a7nAChRs stimulation did not increase ACh 
release from baseline. Hence, the possibility o f indirect input of bipolar a7nAChRs for 
ACh release was supported. Our results indicate that ACh release through a7nAChRs 
stimulation is possible and specifically the bipolar a7nAChRs release o f ACh via an 
indirect positive feedback mechanism. During excitotoxicity, ACh released by amacrine 
cells, might feedback on bipolar nAChRs to increase ACh release. The neuroprotective 
effect o f  tropisetron on u7nAChRs on isolated RGCs is documented. Our study suggests 
that tropisetron might also protect RGCs through increased ACh release by possible 
indirect modulation. This study indicates the possibility o f dual therapeutic targets o f 
a7nAChRs in the retina for neuroprotection against RGC excitotoxicity.
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CHAPTER I 
INTRODUCTION
Neurodegenerative diseases are the result o f cell death in associated organs like 
the brain, spinal cord and retina. Major causes o f neurodegenerative diseases are 
excitotoxicity, inflammation, genetics, aging, injury and free radical generation (Beal et 
al., 2005). In excitotoxicity, an excitatory neurotransmitter, such as glutamate is increased 
in an associated organ, which causes neuronal cell death (neurodegeneration) by allowing 
an excess o f calcium into the cell (in addition to other proposed mechanisms). 
Excitotoxicity is an important factor associated with many neuronal diseases in the 
central nervous system, including the retina (Choi et al., 1988; Romano et al., 1998; 
Slemmer et al., 2005). Neurodegenerative diseases caused by excitotoxicity in the brain 
include multiple sclerosis, Alzheimer’s disease, amyotrophic lateral sclerosis and 
Parkinson's disease (Kim et al., 2002; Hughes, 2009). Some o f the diseases proposed to 
be caused by excitotoxicity in the retina are diabetic retinopathy, glaucoma and retinal 
ischemia (D’Amico 1994; Brooks et al., 1997; Levin, 2001).
Glaucoma is one o f the major diseases causing blindness in the world. The exact 
mechanisms causing glaucoma have not been fully discovered, but glaucoma is usually 
associated with increased intraocular pressure which is believed to lead to excitotoxicity 
(Vickers et al., 1995; Brooks et al., 1997; Dkhissi et al., 1999). In this disease condition, 
an excess o f non-specific cations enter the retinal ganglion cells (RGCs) o f the retina
which trigger an intracellular signaling cascade, causing apoptotic death (Quigley et al., 
1995; Lam et al., 1999).
In a pig model for glaucoma, excess glutamate can induce blindness. Glutamate 
excites pig RGCs through both NMDA (N-methyl-D-aspartic acid) and non NMDA 
receptors (Wehrwein et al., 2004). NMDA receptors are restricted to the inner retina, and 
the influx o f calcium through NMDA receptors in RGCs is believed to trigger an 
apoptotic cascade. The loss o f RGCs interrupts the normal visual pathway o f the retina, 
eventually leading to blindness.
Visual Pathway
In the visual pathway (Brindley 1970), light entering the eye causes a series of
events and eventually passes electrical and chemical signals to the brain (Figure 1). The
vertical signal transmission is conducted by an excitatory neurotransmitter (glutamate)
from photoreceptors to bipolar cells and horizontal cells (in the outer plexiform layer)
and from bipolar cells to ganglion cells (in the inner plexiform layer) (Massey, 1990).
Horizontal cells excited by the photoreceptor neurotransmitter glutamate provide lateral
complex feedback to bipolar cells and photoreceptors in the outer plexiform layer through
the release o f the inhibitory neurotransmitter GAB A. Bipolar cells, which receive signals
from photoreceptors, pass signals to ganglion cells by making synapses in the inner
plexiform layer where amacrine cells form a much more complex lateral feedback
network. Amacrine cells make synapses with other amacrine cells, bipolar cells and
RGCs (Dowling and Boycott, 1966). The amacrine cells use mainly two inhibitory
neurotransmitters, G ABA (gamma-amino butyric acid) and glycine (Marc, 1995), and a
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subset also use the excitatory neurotransmitter acetylcholine (Famiglietti, 1983) as a co­
transmitter to pass the visual signal.
Normally in the dark, rods and cones (photoreceptors) are in the depolarized state 
and release (Trifonov, 1968) glutamate as a neurotransmitter (Figure 2; Dowling, 1987 
and Massey, 1990). When light is transduced by the photoreceptors, they become 
hyperpolarized and stop releasing glutamate. Due to this effect, one group o f bipolar cells 
(known as OFF- bipolar cells) decreases conductance (Dacheux and Miller, 1976) and 
becomes hyperpolarized via metabotropic glutamate receptors, specifically mGluR6, 
which uses a G protein cascade (Slaughter and Miller, 1983; Nawy and Jahr, 1990; 
Dhingra et al. 2001). OFF bipolar cells glutamate receptors are also known as APB (2- 
amino-4-phosphonobutyrate) sensitive glutamate receptors (Slaughter and Miller, 1981). 
When light is transmitted, the other group o f bipolar cells (known as ON-bipolar cells) 
depolarizes and increases conductance (Nelson, 1973; Toyoda, 1973) through ionotropic 
glutamate receptors i.e. (2-(aminomethyl)phenylacetic acid (AMPA) and kainate 
glutamate receptors; Slaughter and Miller, 1983). Finally, ON bipolar cells (in the dark) 
and OFF bipolar cells (in the light) release glutamate within the inner plexiform layer 
(Werblin and Dowling, 1969; Werblin, 1991), which excites postsynaptic RGCs (Raviola 
and Raviola, 1982) and amacrine cells (Cunningham and Neal, 1985).
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Figure 1. Visual pathway o f the retina. Entered light excites photoreceptors to pass 
signals to bipolar cells (in the outer plexiform layer). Bipolar cells pass the signal to 
ganglion cells (in the inner plexiform layer) which send signals to brain. Horizontal cells 
and amacrine cells provide lateral feedback to the outer and inner plexiform layer 
respectively.
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Figure 2. Visual pathway: Signal transmission from photoreceptors to bipolar cells. In 
the dark, photoreceptors (in depolarized state) release glutamate which depolarizes OFF 
bipolar cells (to release glutamate) and hyperpolarizes ON bipolar cells (to stop glutamate 
release). Vice versa happens in the presence o f light.
Only cholinergic amacrine cells synthesize acetylcholine and release it as a 
neurotransmitter (Masland and Mills, 1979). Hence, cholinergic amacrine cells stimulated 
by bipolar glutamate input release ACh (Famiglietti, 1983; Masland 1988) and pass the 
signal to amacrine cells, bipolar cells and RGCs (Brandon, 1987; Ehinger et al., 1988; 
Marc et al., 1989). When excited, RGCs process and pass the signal received from 
amacrine and bipolar cells through the optic nerve to the brain.
ACh has shown neuroprotective effects on RGCs against excitotoxicity. ACh 
induced neuroprotection o f various central nervous system cells (including RGCs) against 
excitotoxicity has been widely documented (Kaneko et al., 1997; Dajas-Bailador et al., 
2000; O’Neil et al., 2002; Nakamizo et al., 2005; Thompson et al., 2006; Wehrwein et al., 
2004). As described above, in the normal state o f retinal function, glutamate released by 
bipolar cells excites cholinergic amacrine cells which in turn release ACh, an excitatory 
neurotransmitter. ACh release is believed to increase during excess glutamate release as a 
natural defense mechanism against excitotoxicity (Wehrwein et al., 2004). ACh induces 
neuroprotection through activation o f nAChRs. Various studies have shown nAChRs 
induced neuroprotection against excitotoxicity in the brain and retina (Marin et al., 1994; 
Dineley et al., 2001; Lafuente et al., 2001; Laudenbach et al., 2002; Wehrwein et al., 
2004; Thompson et al., 2006). The nAChRs o f the subtype a7 are suggested to be 
involved in the neuroprotection o f the brain (Kaneko et al., 1997 and Dajas-Bailador et 
al., 2000). ACh neuroprotection against glutamate induced excitotoxicity was found to be 
partially mediated through activation o f a7nAChRs (Wehrwein et al., 2004) and 
a4nAChRs (Thompson et al., 2006) in cultured pig RGCs. Furthermore, activation o f
aVnAChRs through tropisetron (a partial aVnAChRs agonist) was found to be 
neuroprotective in pig cultured RGCs (Linn and Linn, 2003 and 2005).
Recently, aVnAChRs have been found on presynaptic neurons o f bipolar cells and 
cholinergic amacrine cells (Dmitrieva NA et al., 200V). Moreover, the stimulation o f 
presynaptic nicotinic acetylcholine receptors o f cholinergic cells has shown to enhance 
ACh release in rat superior cervical ganglion (Liang et al., 199V). In that study, Liang et 
al. demonstrated that positive feedback o f released ACh modulates ACh release through 
nAChRs at the presynaptic level o f cholinergic cells in rat superior cervical ganglion.
Cholinergic and bipolar aVnAChRs might have physiological significant 
functional role in the retina which can be stated based on three results; the 
neuroprotective effect of aVnAChRs on RGCs against glutamate toxicity, the presynaptic 
presence o f aVnAChRs on bipolar and amacrine cells, and a positive modulation o f 
cholinergic cells through nAChRs in rat cervical ganglion.
Objectives
We hypothesized that the stimulation o f cholinergic amarine aVnAChRs and/or 
bipolar aVnAChRs should affect the normal release o f ACh. We predict that there might 
be the presence o f a positive feedback modulation o f ACh release via cholinergic amarine 
and/or bipolar aVnAChRs activation. If  positive feedback modulation o f ACh release 
occurs, there are at least two possible ways o f positive feedback modulation. First, 
cholinergic aVnAChRs activation might directly modulate ACh release from thmselves to 
increase ACh release (direct feedback modulation). Second, if bipolar aVnAChRs are
activated, an increase in the release o f the glutamate neurotransmitter would modulate 
glutamate receptors o f the cholinergic amacrine cells in order to increase release o f  ACh 
(indirect feedback modulation). In the present study, we have stimulated the a7nAChR 
with the partial agonist tropisetron and specific agonist PNU282987.
CHAPTER II 
MATERIALS AND METHODS
The approach in the study is same as previously used by Masland and Livingstone 
(1976) and Linn et al. (1991). Only a subset o f the amacrine cells use ACh as a 
neurotransmitter and are commonly known as the ‘starburst’ amacrine cells based on 
their unique morphology. Only cholinergic amacrine cells synthesize and release ACh as 
a neurotransmitter when excited; because o f this, the cholinergic amacrine cells o f the 
retina can be selectively labeled with radio-labeled choline. ^H-choline take up (via the 
choline transport system) is synthesized to ^H-ACh by cholinergic amacrine cells (via 
choline acetyItranslerase). Released labeled ACh is measured by scintillation counting. 
The materials and methods modified from Masland and Livingstone (1976) and Linn et 
al. (1991) are briefly described below.
Eyecup preparation
Porcine eyes were obtained from local abattoir (DeVries Meats). Eyes were 
obtained from freshly slaughtered animals and were kept on ice until used (usually within 
3 hours). One eye was used for each experiment.
The eyeball was diagonally cut (hemi-sected) into two equal halves in such a way 
that the top portion o f the eyeball, including the lens, was removed and the second half o f 
the eye ball (posterior eyecup), including the optic nerve disc, remained intact. From the 
posterior eyecup, the vitreous humor was removed in order to empty the eyecup.
Dissection was conducted under a red dim light and the remainder o f the study was 
conducted in the dark. Light affects ACh release (see introduction) and we used light as a 
stimulator; hence, the experiment was conducted in the dark or under red dim light 
whenever visual tasks needed to be performed.
Once the eyecup was dissected, it was labeled with ^H-choline Ames solution 
using the steps shown in Figure 3. The eyecup was filled with ^H-choline solution and the 
retina was stimulated with 3 Hz flashing bright white light (light Emitting Diode [LED],
1100 mcd) for 30 minutes (Masland and Livingstone, 1976). According to Masland, 
amacrine cells are thought to release maximum amounts of ACh under light stimulation 
at 3Hz. The application o f light for 30 minutes causes amacrine cells to deplete all the 
unlabelled ACh stores with subsequent uptake o f  ^ H-Choline. During the labeling, the 
eyecup was kept on the small petri-dish containing Ames medium, which was in contact 
with 55°C water to keep the inner temperature o f the eyecup at 37°C. After the labeling, 
the eyecup was transferred to the perfusion chamber.
Preparation o f  ^ H-choline solution
40^1 o f ^ H-choline (tritiated-choline, ^H-Ch; 80 ;/Ci/mmol; New England 
Nuclear) in ethanol was taken into a tube and evaporated to dryness by placing the tube in 
a beaker containing water at 100°C. ^H-choline was redissolved in 1 ml o f Ames media 
(Sigma; Ames and Nesbett, 1981) and held at 37°C until used for labeling.
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Eyecup mounting and perfusion system 
After labeling, the eyecup was tilted upside down and mounted on an eyecup 
support as shown in Figure 4. The eyecup was then held to the eyecup support with a 
ring. The perfiision solution (Ames media) was pumped using variable flow peristaltic 
pump (VWR International) over the eyecup at 37°C at 1.5 ml/minutes. Inflow 
temperature was maintained at 37”C by putting a long loop o f tubing in water maintained 
at 40”C before the perfiision solution flowed over the retina (eyecup). The eyecup was 
washed for 20 minutes so that background activity o f ACh reaches to steady state level. 
The output was collected in a waste beaker.
Ames media 
(37»C)
Small pelri dish ■ 
Water (55*^0 '
Petri dish ■
^H-Choiine 
ames solution
Figure 3. The eyecup set-up used during labeling. The eyecup, which was filled with H- 
choline Ames solution and stimulated with 3Hz o f bright flashing light, was kept in a 
small petri dish containing Ames media. The temperature o f Ames media was maintained 
at approximately 45°C by keeping the small petri dish containing the eyecup in a large 
petri dish heated to 55°C.
11
media Input
retina (inverted 
eye cup)
Ring for eyecup 
support
media
output
Eyecup
support
Figure 4. Perfusion system. The eyecup (inverted) was mounted on a cylindrical shaped 
eyecup support. A plastic ring was used to hold the eyecup to the eyecup support. Input 
media flow was over the top o f the eyecup while output media flow was at the bottom of 
the petri dish.
After a 20 minute washing period, the experiment was started and output was 
collected into vials via a fraction collector. One minute outflow fractions were collected. 
The study was conducted using two types o f stimuli, i.e., light and drugs.
A total o f  four different kinds o f stimuli were used. Except for flashing light, each 
drug was applied for 1 minute through the input o f perfusion solution. 1) 2 to 4 minutes 
o f light stimulation (3 Hz o f bright white light 1100 mcd LED) were applied to assess 
viability o f  the system and physiological input o f the system. 2) Kainate (glutamate 
receptor agonist), which acts specifically on bipolar cells, was applied to validate direct 
selective pharmacological input and as a positive control (Linn et al., 1991). 3) Potassium 
chloride (KCl) was applied to check ACh release through direct depolarization o f  the 
membrane (direct, non selective stimulation; Friedman and Redburn, 1990). 4)
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Tropisetron (partial a7nAChR agonist) and PNU282987 (a7nAChR agonist) were 
applied with or without DNQX (glutamate receptor antagonist) as an experimental 
variable to determine the presence o f a7nAChRs stimulated ACh release.
Even after a prolonged wash (20 minutes), the baseline (background radiation) 
declined steadily throughout the experiment. And so, 5 minutes o f ft-actions were 
collected as the basal efflux before the application o f each stimulus. Tropisetron abruptly 
increased the basal efflux, so 10 to 15 minute washings were taken after its application.
Preparing vials for counting
1 minute fi-actions were subjected to scintillation counting. 2 ml o f EconoScint 
(Packard Fisher) solution was added to each collected ft-action vial. Vials were then 
counted in a standard scintillation counter (Packard CA2200).
Data analysis
Released labeled ACh was detected as Count per Minute (CPMs). The readings o f 
CPM were plotted against the fi-action number o f vials. Each fraction number represents 
either baseline efflux or stimulation induced efflux. The peaks o f agonist induced ACh 
release (labeled) were compared with baseline efflux o f ACh. The average fold increase 
(response /  preceding basal efflux) o f  the stimuli was plotted against respective stimuli. 
Statistical analysis was done using One way ANOVA followed by student-Newman- 
Keuls test o f post-hoc analysis. P-values less than 0.05 were considered as significant.
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CHAPTER III
RESULTS
Physiological and Pharmacological stimuli 
We calibrated the responses o f the pig retina in vitro system using physiological 
and pharmacological stimuli. After 20 minutes o f washing, background radioactivity 
reached a steady state level. Light was used as a stimulus to release ACh (^H labeled), to 
ensure that the physiological responsiveness o f the retina was intact through 
photoreceptor activation. 3 Hz flashing light was applied for 2 to 4 minutes giving a 2 to 
3 fold increase in ACh release (Figure 5 or 6). This is comparable to what Masland 
(1976) demonstrated and was used to indicate a functional retina.
We presumed that the released radioactivity by stimuli was in the form o f ACh 
rather than another metabolite or choline. Previous work has indicated that essentially all 
the radioactivity released due to light was in the form o f ACh (Masland and Livingstone, 
1976; Massey and Neal, 1979; Massey and Redbum, 1982). Moreover, the analysis of 
released ACh by stimuli like kainate (KA), quisqualate (QQ) and NMDA has shown that 
more than 90% of radioactivity was ACh as opposed to choline (Linn et al., 1991).
Kainate (KA) is a selective KA receptor agonist, since KA receptors have been 
demonstrated to be the physiologically activated receptor on cholinergic amacrine cells 
(Linn et al., 1991) and bipolar cells. We used kainite as a selective pharmacological input 
to kainite receptors o f bipolar and cholinergic amacrine cells. Our results showed that the
14
average fold increase o f ACh release compared to respective basal efflux was 2.06 fold 
by light, 1.81 by 10 pM kainate and 2.45 by 100 pM kainate (Figure 6).
We used KCl to insure that ACb release was working through direct chemical 
stimulation. Elevated KCl is often used as a, non-selective input to depolarize the plasma 
membrane o f cholinergic amacrine cells (Friedman & Redburn, 1990). Our results 
indicated that elevated potassium (100 mM KCl) caused up to a 7 fold increase in basal 
efflux (Figures 5 and 6).
In this study, direct pharmacological (kainate) and physiological (light) input had 
increased ACh release compared to base line, and essentially functioned as our positive 
controls to validate the system.
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Figure 5. ACh release (CPMs) changes in the presence o f light, kainate and KCl (control 
stimulators). Release o f ACh from pig retina {in vitro) in response to stimulation by light, 
100 |iM kainate and 100 mM KCl. Release data in CPMs were plotted against the 
fraction number. One-minute fractions were collected, and kainate (glutamate receptor 
agonist) and KCl (non selective input, membrane depolarizer) were applied for 1 minute. 
Light stimulation at 3 Hz for 2 minutes.
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98
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Light (n=7) 10 pM Kainate 100 pM Kainate 100 mM KCI
(n=3) (n=8) (n=2)
Physiological Pharmacological
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Figure 6. Average fold increase o f ACh release due to light, kainate and KCI (control 
stimulators). The summary o f data (ACh release in pig retina in vitro) collected for 
different positive controls used in the study to validate the system, light (flashing white -3 
Hz) functions as a physiological stimuli, kainate as pharmacological stimuli and 
potassium (KCI) as membrane cell depolarizer. The average fold increase in ACh release 
compared to the respective baseline verses control stimulators was plotted in the graph.
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Partial agonist o f a7nAChRs -  Tropisetron 
Tropisetron ((3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 1H-indole-3- 
carboxylic acid ester monohydrochloride) has potent 5 -HT3 (serotonin, 5- 
hydroxytryptamine) receptor antagonistic & anti-emetic activity (Seynaeve et al., 1991; 
Middlemiss and Tricklebank, 1992; Mhatre et al., 2004). It has partial aVnAChRs activity 
(Papke et al., 2005) and has shown neuroprotection o f  RGCs against glutamate toxicity in 
RGCs culture (Linn and Linn, 2003 and 2005). Moreover, it has passed clinical trials and 
is used as an antiemetic (anti-vomiting) outside o f the US. Hence, its effect on 
aVnAChRs mediated ACh release might be valuable.
Tropisetron increased ACh release compared to basal efflux from 1.13 fold to 
2.79 fold in a dose dependent manner. Figure 7 shows the result o f one experiment. Peaks 
o f increased ACh release are seen with three different tropisetron concentrations. The 
data suggests concentration o f tropisetron in 0.01-100 nM tropisetron had 1.13 fold-2.79 
fold increases in ACh release compared to basal efflux.
Figure 8 shows summary o f  tropisetron experiments. ACh release induced by 1 
nM and 100 nM tropisetron concentrations is significantly different from the ACh release 
induced by 0.01 nM tropisetron concentration (P<0.05). However, ACh release induced 
by 1 nM and 100 nM tropisetron is not significantly different from each other (Figure 8).
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Figure 7. ACh release (CPMs) changes in the presence o f different concentrations of 
tropisetron. Release data in CPMs were plotted against the fraction number. One-minute 
fractions were collected, and different concentrations o f tropisetron were applied for 1 
minute. The washtime between two applications o f tropisetron were more than 10 
minutes. Normally a steady decline in radioactivity is observed, due to the finite pool of 
releasable ACh.
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Figure 8. Average fold increase in ACh release for different concentrations o f tropisetron. 
The average fold increase in ACh release compared to the respective preceding baseline 
verses different concentrations o f tropisetron was plotted in the graph. * P<0.05 from 
0.01 nM tropisetron (One way ANOVA, Student-Newman-Keuls test o f post-hoc 
analysis).
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Specific agonist o f aTnAChRs -  PNU 282987 
(N-(3R)-l-Azabicyclo[2.2.2]oct-3-yl-4-chlorobenzamide; Tocris Bioscience)
PNU has shown neuroprotective activity on RGCs against glutamate toxicity.
Here it was used as a selective agonist for aTnAChRs stimulation. We observed increased
efflux after tropisetron application and PNU 282987 also increased ACh release
compared to a basal efflux (Figure 9).
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Figure 9. Release o f ACh from pig retina {in vitro) in response to stimulation by light, 
kainate, PNU282987 and tropisetron. Release data in CPMs were plotted against the 
fraction number. One-minute fractions were collected, and different concentrations of 
tropisetron were applied for 1 minute. Washing timings between the application o f 
PNU282987 and tropisetron were kept more than 10 minutes. Light stimulation at 3 Hz 
for 2 minutes.
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KA antagonist - DNQX and a7nAChR agonist PNU-282987 
Stimulation of a7nAChRs by tropisetron and PNU 282987 increased ACh release 
compared to basal efflux. 6,7-dinitroquinoxaline-2,3-dione (DNQX) is a glutamate 
receptor antagonist (a selective KA receptor antagonist, Linn et al. 1991). It is used to 
differentiate between a direct (cholinergic a7nAChRS mediated) or indirect (bipolar 
a7nAChRS mediated) effect o f ACh release (Linn & Massey, 1992). lOpM DNQX 
blocks the effect o f KA and physiological stimuli (light) on cholinergic amacrine cells 
completely (Linn et al., 1991). We blocked KA receptors with DNQX with alO minute 
pre-treatment before PNU 282987 application. Light, 100 pM Kainate and 100 pM PNU 
282987 were applied with and without DNQX application. There was an increase in ACh 
release compared to basal efflux with application o f light, kainate and PNU 282987 in the 
absence o f DNQX; while there was no change in ACh release compared to baseline in the 
presence o f DNQX in response to stimulation (Figure 10).
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Figure 10. Release o f  ACh from pig retina (in vitro) in response to stimulation by light, 
kainate, PNU282987 in the presence and absence o f DNQX. Release data in CPMs were 
plotted against the fraction number. One-minute fractions were collected, and different 
concentrations o f tropisetron were applied for 1 minute.
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CHAPTER IV
DISCUSSION
Stimulation o f a7nAChRs by agonists (e.g. tropisetron or PNU282987) increased 
the ACh release compared to basal efflux suggesting possible involvement o f either 
cholinergic a7nAChRs and/or bipolar a7nAChRs (Figures 7, 8, and 9). Our results 
indicated that in the presence o f DNQX (glutamate receptor blocker), the blockade o f 
light and kainate induced ACh release is observed; which is consistent with the previous 
findings by Linn et al., 1991 (Figure 10). To find out which a7nAChRs (either 
cholinergic or bipolar a7nAChRs) mediated ACh modulation, we used DNQX. In the 
presence o f DNQX, the KA receptors o f cholinergic amacrine cells are blocked. lOpM 
DNQX blocks all the inputs from kainate and light. Hence, DNQX blocks glutamate 
input from bipolar cells to cholinergic amacrine cells (Linn et al., 1991). Basically, if the 
modulation is through direct effects on the cholinergic amacrine cell, this modulation 
should not be affected.
There are two possibilities for positive feedback modulation: I) amacrine cell 
a7nAChRs mediated (direct positive feedback modulation) and 2) bipolar a7nAChR 
mediated (indirect positive feedback modulation). In the presence o f DNQX, bipolar cell 
mediated ACh release should be blocked and not induce ACh release above baseline. 
This is based on the hypothesis that glutamate (released by bipolar a7nAChR activation) 
input to amacrine cells will be blocked in the presence o f  DNQX. Moreover, if ACh
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release is mediated by a7nAChRs in the cholinergic amacrine cells, ACh release should 
increase compared to baseline even in the presence o f DNQX.
Our study showed an increase in ACh release when a7nAChRs agonists 
(tropisetron and PNU282987) were applied (Figures 7, 8, and 9) in the absence of 
DNQX. However, in the presence o f  DNQX, there was no increase in ACh release 
compared to baseline (Figure 10). This does not support the possibility o f  a significant 
role o f a7nAChRs in the cholinergic amacrine cells in the modulation o f ACh release. 
Hence, bipolar a7nAChRs induced ACh release might be a possible mechanism (indirect 
positive feedback modulation). See figure 11 for a model explaining positive feedback 
modulation based on our results.
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Figure 11. Model explaining positive feedback modulation. The figure shows 
neurotransmitter network o f  glutamate and ACh among bipolar cells, cholinergic cells 
and RGCs. Photoreceptors passes glutamate neurotransmitter signal to bipolar cells and 
horizontal cells. Bipolar cells passes glutamate neurotransmitter signal to cholinergic 
amacrine cells and RGCs. Cholinergic amacrine cells might feedback ACh to bipolar 
aVnAChRs as an indirect positive feedback modulation o f ACh release.
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This study supported the possibility o f  ACh release mediated by indirect positive 
feedback through the activation o f bipolar aTnAChRs. As shown in figure in 7, ACh 
release through the stimulation o f aTnAChRs is possible. Amacrine cells might get 
indirect positive feedback from ACh, inducing them to release more ACh (Figures 8 and 
11). During excitotoxicity, ACh released by amacrine cells, might feedback on bipolar 
nAChRs to increase ACh release. This finding is significant. Normally, it would not be 
expected to see any increase if aTnAChRs were only physiologically important on RGCs. 
There is no known feedback from RGCs onto the cholinergic amacrine cells. So, this 
effect has to be direct or pre-synaptic (onto a cell that synapses onto the cholinergics).
Interestingly, activation o f bipolar aTnAChRs modulated ACh release while 
cholinergic aTnAChRs did not. This raises questions regarding the physiological 
significance of the cholinergic aTnAChRs (Figure 11). We are hesitant to minimize the 
importance o f the cholinergic aTnAChRs based on the findings o f only one approach 
(ACh release), particularly since the effects o f the bipolar synapse could be amplified 
through the high-gain, ‘ribbon’ synapse (Linn & Massey, 1992). Moreover, if aTnAChRs 
are only physiological significant, one would not expect any increase in ACh release 
through the stimulation o f aTnAChRs.
Bipolar aTnAChRs in bipolar cell synaptic terminals receive GABAergic negative 
feedback from amacrine cells (Yazulla et al., 198T). At bipolar cell terminals, G ABA 
inhibits C a^  conductance by acting through metabotropic GABAb receptors. Decreased 
Ca^^ conductance inhibits glutamate neurotransmitter release from bipolar synaptic 
terminals (Heidelberger and Matthews, 1991). Our experiments indicate a possible
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enhancement o f glutamate release through the stimulation o f bipolar aTnAChRs. 
Opposing the negative GABAergic negative feedback, an increase in bipolar C a^  levels 
might be central to aTnAChR mediated glutamate release (Rogers and Dani, 1995; 
Ragozzino et al., 1998).
Though we calibrated the in-vitro system o f the pig retina, it should be kept in 
mind that the previous in-vivo studies o f rabbit retina (Linn et al. 1991) induced 
significantly higher increases in ACh release when glutamate analogues were applied. 
This suggests a limitation o f  our model. However, our results are comparable to other in- 
vitro preparations examining ACh release from the rabbit retina (Masland & Livingstone, 
1976; Friedman & Redburn, 1990) and rat nervous tissue (Liang & Vizi, 1997). This 
indicates that our results may underestimate the in vivo effect o f glutamate analogue.
Previous research indicated that RGC neuroprotection from excitotoxicity through 
the stimulation o f RGC aTnAChRs by tropisetron is possible (Linn and Linn, 2003). The 
present study indicates that the stimulation o f bipolar aTnAChRs by tropisetron also 
caused ACh release. This raises the possibility o f dual therapeutic targets for RGCs 
neuroprotection through direct action on RGC aTnAChRs & indirect action on bipolar 
aTnAChRs. Neuroprotection o f RGCs is critically important in glaucoma and our study 
suggests that the stimulation o f aTnAChRs using drugs like tropisetron, which is 
clinically approved, might be therapeutically targeted in dual way for protection o f RGCs 
against excitotoxicity. However, the presence o f aTnAChRs on bipolar cells, RGCs and 
various amacrine cells including cholinergic amacrine cells (Dmitrieva et al. 200T)
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suggests a complex and ‘layered’ control o f ACh release and requires further study to 
understand a7nAChR mediated neuroprotection.
Further exploration o f this 'layered' structure would probably involve more direct 
monitoring o f individual cells, such as with whole-cell recording. In their investigations 
o f the GABA-B receptor on bipolar cells, Maguire et al (1989) used the retinal slice 
preparation to record from bipolar cells with and without intact axons. Responses to 
GABA-B agonists were only found on bipolars with intact axons indicating their 
localization to the axon terminal. One would assume that the alpha? receptors are also 
restricted to the axon terminal since they appear to increase neurotransmitter release. The 
intracellular mechanisms o f this increase also deserve further investigation. One would 
assume that they increase the permeability o f specific calcium channels involved in 
neurotransmitter release. This mechanism would be in contrast to the neuroprotective 
mechanism invoked by alpha? activation on RGCs. The mechanism o f action o f alpha? 
receptors on amacrine (particularly the cholinergic) cells will probably be more elusive 
since currently there is not a way to selectively culture these cells (as there is with the 
RGCs) and they are more difficult to directly record from compared to bipolar cells.
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